文献速递小儿骨科

2017年ABJS Nicolas Andry奖:通过转化研究推进马蹄内翻足的个性化医疗

The 2017 ABJS Nicolas Andry Award: Advancing Personalized Medicine for Clubfoot Through Translational Research.
PubMed 文献 · Clin Orthop Relat Res · 2017-02-24

本文为2017年ABJS Nicolas Andry奖报告,围绕马蹄内翻足的遗传与形态学异常及个性化治疗展开。研究通过人类基因测序、小鼠模型基因工程、MRI及新治疗方法开发,发现PITX1-TBX4-HOXC转录通路突变可致家族性马蹄内翻足和垂直距骨,MRI所示肌肉、骨骼及血管形态异常既是基因突变的关联表现,也是治疗抵抗性马蹄内翻足的生物标志物。基于这些生物学认识,作者改进了被忽视型和综合征型马蹄内翻足的治疗方法,开发了基于Ponseti原则的先天性垂直距骨新疗法,并设计了一种新型动态马蹄内翻足支具以提高力量和依从性。

要点

  • PITX1-TBX4-HOXC转录通路突变可致家族性马蹄内翻足和垂直距骨,这些基因在下肢的特异性表达可解释上肢未受累。
  • MRI显示肌肉、骨骼和血管形态异常,这些异常与基因突变相关,并可作为治疗抵抗性马蹄内翻足的生物标志物。
  • 基于生物学认识改进了被忽视型和综合征型马蹄内翻足的治疗,开发了先天性垂直距骨新疗法和新型动态支具。

核心结论

  • 基于对马蹄内翻足潜在生物学的理解,作者改进了被忽视型和综合征型马蹄内翻足的治疗方法,开发了基于Ponseti原则的先天性垂直距骨新疗法,并设计了新型动态马蹄内翻足支具以提高力量和依从性。

研究设计与样本

  • 本研究为转化研究,采用人类基因测序、小鼠马蹄内翻足模型的分子遗传工程、马蹄内翻足MRI以及新治疗方法开发等方法。

主要发现

  • PITX1-TBX4-HOXC转录通路突变在少数家系中导致家族性马蹄内翻足和垂直距骨,这些基因在下肢的特异性表达可解释这类疾病上肢未受累。
  • MRI研究显示相应的形态学异常,包括肌肉、骨骼和血管发育不良,这些异常不仅与基因突变相关,也是治疗抵抗性马蹄内翻足的生物标志物。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Clubfoot is one of the most common pediatric orthopaedic disorders. While the Ponseti method has revolutionized clubfoot treatment, it is not effective for all patients. When the Ponseti method does not correct the foot, patients are at risk for lifelong disability and may require more-extensive surgery. QUESTIONS/PURPOSES: (1) What genetic and morphologic abnormalities contribute to the development of clubfoot? (2) How can this information be used to devise personalized treatment paradigms for patients with clubfoot? METHODS: Human gene sequencing, molecular genetic engineering of mouse models of clubfoot, MRI of clubfoot, and development of new treatment methods all have been used by our group to understand the biological basis and improve therapy for this group of disorders. RESULTS: We gained new insight into clubfoot pathogenesis from our discovery that mutations in the PITX1-TBX4-HOXC transcriptional pathway cause familial clubfoot and vertical talus in a small number of families, with the unique lower limb expression of these genes providing an explanation for the lack of upper extremity involvement in these disorders. MRI studies revealed corresponding morphologic abnormalities, including hypomorphic muscle, bone, and vasculature, that are not only associated with these gene mutations, but also are biomarkers for treatment-resistant clubfoot. CONCLUSIONS: Based on an understanding of the underlying biology, we improved treatment methods for neglected and syndromic clubfoot, developed new treatment for congenital vertical talus based on the principles of the Ponseti method, and designed a new dynamic clubfoot brace to improve strength and compliance.

来源:Clin Orthop Relat Res,查看原文。版权归原作者所有。

引用

  1. Dobbs MB, Gurnett CA. The 2017 ABJS Nicolas Andry Award: Advancing Personalized Medicine for Clubfoot Through Translational Research. Clin Orthop Relat Res. 2017. PMID: 28236079. doi:10.1007/s11999-017-5290-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。